Clinical Trial Update: A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a peptide vaccine for Esophageal Cancer. The sponsor is University of Yamanashi and the current status is listed as UNKNOWN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: University of Yamanashi | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN